Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject
作者： Eric C. Leuthardt , Dennis J. Rivet , Elizabeth A. Sweeney , Muriel Y. Ishikawa , Roderick A. Hyde
DOI:
关键词:
摘要: A method for treating cardiovascular disease in a mammalian subject includes providing to the at least one treatment regimen including estrogen receptor modulator, wherein is determined based on APOE allelic profile subject, and steroid hormone levels prior diagnosis current subject.
lens.org 参考文章(64)
Morris Notelovitz, Methods for reducing the risk of breast cancer in and improving the health of women ,(2003)
Michael B. Foster, Method of optimizing growth hormone replacement ,(2002)
David S. Bettinger, Programmable transdermal therapeutic apparatus ,(1999)
David Herrington, Gregory Hawkins, Timothy Howard, Deborah Meyers, Genetic polymorphisms of estrogen receptor alpha associated with favorable HDL cholesterol response to hormone replacement therapy ,(2002)
Vivian Dullien, Hormone replacement therapy monitoring ,(1999)
Benjamin L. Lewis, Mitchell Litt, Daniel Malamud, Remote control drug delivery device Official Gazette of the United States Patent and Trademark Office Patents. ,(1998)
David King, Paul Lum, Dominique Freeman, Tad Simons, Michael Greenstein, Apparatus and method for minimally invasive blood sampling ,(1997)
Elie S. Nuwayser, Method of transdermal drug delivery ,(1984)
Jonathan V. Wright, Hormone replacement formulation ,(2006)
Jack W. Schwartz, Alfred Kwiatek, Device for the administration of an active agent to the skin or mucosa ,(1984)